Osteoporosis treatment with zoledronic acid in pediatric population at a university hospital in Western Saudi Arabia: A 13-year experience

Abdulmoein E. Al-Agha; Rahaf S. Hayatalhazmi

doi:10.15537/smj.2015.11.12590

Article Information

vol. 36 no. 11 1312-1318

DOI

https://doi.org/10.15537/smj.2015.11.12590

PubMed

26593164

Published By

Saudi Medical Journal

Online ISSN

1658-3175

History

Received June 11, 2015
Accepted September 22, 2015
Published online November 1, 2015.

Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

Abdulmoein E. Al-Agha, FRCPCH ⇑ and
Rahaf S. Hayatalhazmi, MBBS

From the Department of Pediatrics (Al-Agha), Faculty of Medicine, King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia, and Department of Family Medicine (Hayatalhazmi), Faculty of Health, Maastricht University, Maastricht, Netherlands

Address correspondence and reprint request to: Dr. Abdulmoein E. Al-Agha, Department of Pediatrics, Faculty of Medicine, King Abdulaziz University Hospital, PO Box 80215, Jeddah 21589, Kingdom of Saudi Arabia. E-mail: aagha{at}kau.edu.sa

View Full Text